7/26/2023 0 Comments Jnj covid vaccine production![]() Gavi, as a co-lead of COVAX, said it “proactively supports the expansion of regional manufacturing efforts as a fundamental cornerstone of future pandemic preparedness”. Nkengasong said that discussions have begun with Gavi, The Vaccine Alliance, and COVAX on the possibility of ordering COVID-19 vaccine doses from Aspen Pharmacare to ensure that the facility does not suspend its COVID-19 vaccine production line. ![]() Johnson & Johnson did not comment on a potential halt to production of COVID-19 vaccines, but said that it is aware of the challenges that vaccine manufacturers are experiencing as demand for COVID-19 vaccines evolves globally. However, no African countries have so far bought doses from Aspen. “It gets us one step closer to securing Africa's future vaccine production and ensures that the gross vaccine inequality we witnessed in the early part of the pandemic is not repeated”, Masiyiwa said in November, 2021. Strive Masiyiwa, African Union special envoy on COVID-19 and head of the African Vaccine Acquisition Trust, which brokered the agreement with Johnson & Johnson, said the contract is for 400 million doses. Under the agreement, Aspen can fill vials with vaccine supplied by Johnson & Johnson, package the vaccine doses, and sell the finished form in Africa. He described such reluctance as short-sighted. Of the 760 million total doses the continent has received, nearly 507 million have been administered. As of April 25, 16% of the African population had been fully vaccinated. Nkengasong noted that countries are reluctant to pay for Aspen's vaccine doses because hundreds of millions of free doses are now widely available-with some now struggling to quickly roll out the shots before they expire. He added that if this situation continues “the risk is very, very high that the company may actually stop producing the J&J COVID vaccines”. ![]() At a press briefing on April 14, the Africa CDC's Director John Nkengasong told journalists that countries are not ordering the vaccine. However, this plan could be undercut by a lack of demand.Īn agreement to bolster manufacturing of Johnson & Johnson's single-dose vaccine was secured by South Africa-based Aspen Pharmacare in December, 2021. A new plan aims to enable Africa to locally manufacture 60% of its vaccine needs by 2040. In March, the Africa Centres for Disease Control and Prevention (CDC) warned that less than 1% of vaccines administered on the continent are manufactured locally, reducing countries’ ability to respond to pandemics and other health crises. Global inequities in access to COVID-19 vaccines, diagnostics, and therapeutics have prompted a huge push to expand local manufacture of health technologies in Africa. Our commitment to families around the world doesn’t change in a time of crisis: we’ll never stop taking care of you.A lack of demand could jeopardise manufacturing of the Johnson & Johnson vaccine in South Africa. The Johnson & Johnson COVID-19 vaccine is an important choice for people who can’t or won’t return for multiple vaccinations or who would remain unvaccinated without an alternative, and aligns with the World Health Organization’s (WHO) recommendations for medical interventions in a pandemic setting, which emphasize ease of distribution, administration, and compliance. Vaccines like ours are playing a crucial role in preventing severe disease, hospitalizations and deaths, protecting hundreds of millions of people from serious and fatal outcomes of COVID-19. Our vaccine development technology, scientific expertise and global manufacturing capabilities provided a foundation to develop a vaccine candidate and upscale production so that we can get it in the hands of those who need it most, as quickly and as safely as possible. Vaccines have been a critical component in tackling the COVID-19 pandemic. We have done it before, and we will do it again. We have an enduring track record of tackling the world’s greatest health challenges, from tuberculosis to Ebola to HIV, with innovative solutions. That’s why from the very beginning, we have taken a stand against COVID-19 on a global scale. T Johnson & Johnson, we believe it is our responsibility to protect people, especially the most vulnerable, from the world’s most challenging and wide-reaching infectious diseases like COVID-19.
0 Comments
Leave a Reply. |